(Adds shares in paragraph 2, details in paragraph 5, 8, and 9, background in paragraph 6, 7, 10 and 11) Oct 8 (Reuters) – Drugmaker Viatris will buy Pacira BioSciences for $1.65 billion in an all-cash
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
EU APPROVAL SEEN AFTER REGULATORS' PRELIMINARY REVIEW, SOURCES SAY (The article has been published through…
VIDEO SHOWS: PRESS CONFERENCE COMMENTS FROM FIFA PRESIDENT GIANNI INFANTINO AND CAF PRESIDENT PATRICE MOTSEPE…
Sundeep Bhutoria inaugurates India National Stand at Frankfurt Book Fair 2026 with Deepak Bansal, Yuvraj…
Oct 8 (Reuters) - Spotify said on Thursday it had signed a new multiyear licensing…
By Hannah Lang Oct 8 (Reuters) - Digital asset company Securitize is launching blockchain-based tokenized…
By Amy-Jo Crowley LONDON, Oct 8 (Reuters) - Britain's BBC and Channel 4 have held…